Citigroup’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $586K | Sell |
61,527
-133,428
| -68% | -$1.27M | ﹤0.01% | 2841 |
|
|
2025
Q1 | $2.04M | Buy |
194,955
+52,038
| +36% | +$544K | ﹤0.01% | 2073 |
|
|
2024
Q4 | $3.37M | Buy |
142,917
+78,479
| +122% | +$1.85M | ﹤0.01% | 1744 |
|
|
2024
Q3 | $2.31M | Buy |
64,438
+27,725
| +76% | +$996K | ﹤0.01% | 1927 |
|
|
2024
Q2 | $1.3M | Sell |
36,713
-263,414
| -88% | -$9.3M | ﹤0.01% | 2074 |
|
|
2024
Q1 | $8.52M | Buy |
300,127
+228,523
| +319% | +$6.49M | 0.01% | 962 |
|
|
2023
Q4 | $952K | Buy |
71,604
+9,709
| +16% | +$129K | ﹤0.01% | 2187 |
|
|
2023
Q3 | $555K | Buy |
61,895
+11,508
| +23% | +$103K | ﹤0.01% | 2337 |
|
|
2023
Q2 | $567K | Buy |
50,387
+45,942
| +1,034% | +$517K | ﹤0.01% | 2656 |
|
|
2023
Q1 | $51.2K | Sell |
4,445
-5,724
| -56% | -$65.9K | ﹤0.01% | 3623 |
|
|
2022
Q4 | $118K | Sell |
10,169
-116,409
| -92% | -$1.35M | ﹤0.01% | 3274 |
|
|
2022
Q3 | $1.61M | Sell |
126,578
-276,078
| -69% | -$3.51M | ﹤0.01% | 1757 |
|
|
2022
Q2 | $2.77M | Buy |
402,656
+395,230
| +5,322% | +$2.71M | ﹤0.01% | 1387 |
|
|
2022
Q1 | $72K | Sell |
7,426
-6,493
| -47% | -$63K | ﹤0.01% | 3879 |
|
|
2021
Q4 | $165K | Buy |
13,919
+10,128
| +267% | +$120K | ﹤0.01% | 3695 |
|
|
2021
Q3 | $62K | Buy |
3,791
+1,913
| +102% | +$31.3K | ﹤0.01% | 3883 |
|
|
2021
Q2 | $40K | Buy |
1,878
+810
| +76% | +$17.3K | ﹤0.01% | 4252 |
|
|
2021
Q1 | $17K | Sell |
1,068
-1,591
| -60% | -$25.3K | ﹤0.01% | 4674 |
|
|
2020
Q4 | $56K | Buy |
+2,659
| New | +$56K | ﹤0.01% | 4025 |
|